![](https://investorshub.advfn.com/uicon/8777.png?cb=1703671008)
Tuesday, September 29, 2020 8:02:51 AM
https://fintel.io/so/us/syrs
Recent SYRS News
- Syros to Host Webcast Event on Higher-Risk Myelodysplastic Syndrome and the Opportunity for Tamibarotene to Become the New Frontline Standard-of-Care for Patients with RARA Gene Overexpression • Business Wire • 06/13/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:30:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:30:54 PM
- Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update • Business Wire • 05/14/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 10:42:01 AM
- Syros to Participate in Upcoming Investor Conferences • Business Wire • 05/07/2024 01:00:00 PM
- Syros to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024 • Business Wire • 05/07/2024 11:00:00 AM
- Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression • Business Wire • 04/09/2024 11:00:00 AM
- Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/02/2024 08:30:00 PM
- Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update • Business Wire • 03/27/2024 11:30:00 AM
- U.S. Stock Index Futures Point to a Rebound, Oil See Declines in Early Trading • IH Market News • 03/27/2024 10:57:08 AM
- Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial • Business Wire • 03/25/2024 11:00:00 AM
- Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024 • Business Wire • 03/20/2024 11:00:00 AM
- Syros to Participate in TD Cowen 44th Annual Health Care Conference • Business Wire • 02/27/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/15/2024 01:56:21 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:22:30 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 12:02:26 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 11:59:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:06:32 PM
- Syros Highlights Anticipated 2024 Milestones to Deliver on the Value of Tamibarotene • Business Wire • 01/08/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/02/2024 09:15:13 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/26/2023 10:19:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:59:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/19/2023 09:53:10 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM